Drug intelligence / Profile preview

SHED-CM

Development stage
Phase 1
Lead developer
U-factor
Modality
Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Topical, Intracavernosal Injection, Intrathecal, Inhalation, Subcutaneous, Intradermal, Intra-articular Injection
01

Overview

SHED-CM is the conditioned medium derived from stem cells obtained from human exfoliated deciduous teeth (SHEDs). It contains a rich secretome of bioactive factors, including growth factors such as vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), and transforming growth factor-beta (TGF-β), as well as neurotrophic factors and cytokines. These components contribute to its regenerative, neuroprotective, angiogenic, and immunomodulatory effects. The mechanism of action involves paracrine signaling that promotes tissue repair by stimulating cell proliferation, differentiation, angiogenesis via VEGF activation of endothelial cells, modulation of immune responses through cytokine secretion and regulatory T cell induction, suppression of oxidative stress in neurons via heat shock protein upregulation and insulin-like growth factor-1 receptor activation. SHED-CM has been investigated for use in amyotrophic lateral sclerosis (ALS), erectile dysfunction (by repairing vascular endothelium), oral wound healing/regeneration in nanoemulgel formulations, acute lung injury/fibrosis models in animals, and other systemic diseases with inflammatory or degenerative components[1][2][3][4][5][6].

Brand names
U-factor
Other names
Stem cells from human exfoliated deciduous teeth-conditioned mediumConditioned medium of stem cells from human exfoliated deciduous teethSHED conditioned medium
02

Targets

MET (Mesenchymal-epithelial transition factor receptor)IGF-1R (Insulin-like growth factor 1 receptor)TGFBR (TGF-beta receptor)VEGFR (VEGFR family)

Beyond the preview

Go deeper on SHED-CM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SHED-CM.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call